This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Hoffmann-La Roche Inc., Societe De Conseils De Recherches Et D'applications Scientifiques. Active years: 2008-2010.
Location History:
- Zurich, CH (2008)
- Zürich, CH (2010)
Company Filing History:
1 out of 5,016 
1 out of 73 Years Active: 2008-2010
Title: The Innovative Contributions of Rene Peters
Introduction
Rene Peters is a notable inventor based in Zurich, Switzerland. She has made significant contributions to the field of chemistry, particularly in the production of useful intermediates for pharmaceutical applications. With a total of 2 patents, her work has garnered attention for its potential impact on drug development.
Latest Patents
Rene Peters' latest patents include innovative processes that enhance the production of valuable chemical compounds. One of her patents focuses on a new process for the asymmetric production of 3-(pyridin-4-yl)-3-hydroxy-pentanoic acid derivatives. These derivatives are recognized as useful intermediates in the manufacture of compounds that exhibit antiproliferative activity. Another significant patent involves a process for the manufacture of intermediates in camptothecin production. This invention provides a method for creating a key intermediate that is crucial in the synthesis of camptothecin, a compound that continues to be a promising lead structure for the development of new anti-cancer drugs.
Career Highlights
Throughout her career, Rene Peters has worked with esteemed organizations such as Société de Conseils de Recherches et d'Applications Scientifiques and Hoffmann-La Roche Inc. Her experience in these companies has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Rene has collaborated with notable professionals in her field, including Christian Diolez and Eric Manginot. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.
Conclusion
Rene Peters is a distinguished inventor whose work in the production of chemical intermediates has the potential to advance the development of new therapeutic agents. Her contributions to the field of chemistry are noteworthy and continue to inspire future innovations.